it enhances both glutamatergic and GABAergic synaptic transmission. In the present study, we examined whether dopamine receptors might contribute to the nicotineinduced inhibition of synaptic potentiation. The nicotine-induced inhibition of synaptic potentiation was decreased in the presence of a D1 dopamine receptor antagonist SCH23390 irrespective of the presence of a D2 dopamine receptor antagonist sulpiride, suggesting that D1 dopamine receptors are involved in nicotine-induced inhibition. We also investigated how dopamine receptors might contribute to the nAChR-induced enhancement of glutamatergic and GABAergic synaptic transmission. The nAChR-induced enhancement of GABAergic synaptic transmission was decreased in the presence of SCH23390 irrespective of the presence of sulpiride, whereas that of glutamatergic synaptic transmission was not altered in the presence of SCH23390 and sulpiride. These results suggest that D1 dopamine receptors are involved in the nAChR-induced enhancement of GABAergic synaptic transmission while dopamine receptors are not involved in that of glutamatergic synaptic transmission. These observations indicate that the interaction between nAChRs and D1 dopamine receptors plays critical roles in synaptic activities in layer 5 pyramidal neurons of the mouse insular cortex. These insular synaptic changes might be associated with nicotine addiction.
K E Y W O R D S
dopamine receptor, insular cortex, nicotinic acetylcholine receptor, pyramidal neuron, synaptic plasticity reduces nicotine self-administration and reinstatement in rats (Forget, Pushparaj, & Le Foll, 2010; Pushparaj, Kim, Musiol, Trigo, & Foll, 2015) .
However, the cellular and synaptic mechanisms associated with nicotine addiction remain largely unknown.
Nicotinic acetylcholine receptors (nAChRs) play critical roles in nicotine reward, dependence, and withdrawal (Sharma & Vijayaraghavan, 2008) . The nAChR systems interact with other neural systems such as dopamine, GABA, and glutamate systems, which also play pivotal roles in the development of nicotine addiction. Particularly, it is considered that dopamine systems are essential components for rewarding and dependence properties of nicotine (De Biasi & Dani, 2011) . For instance, subcutaneous injections of D1 and D2 dopamine receptor antagonists decreased nicotine-induced hyperactivity in rats (O'Neill, Dourish, & Iversen, 1991) and also reduced nicotine self-administration in rats (Corrigall & Coen, 1991) . Furthermore, local infusions of a D1 dopamine receptor antagonist SCH23390 into the nucleus accumbens shell and agranular insular cortex decreased nicotine self-administration in rats (Hall, Slade, Allenby, Kutlu, & Levin, 2015; Kutlu et al., 2013) .
We have previously shown that in layer 5 pyramidal neurons of the agranular insular cortex, activation of nAChRs suppresses synaptic potentiation through enhancing GABAergic synaptic transmission (Sato, Kawano, Yin, Kato, & Toyoda, 2017) . However, it is well known that the insular cortex receives synaptic inputs from glutamatergic and GABAergic neurons as well as from dopaminergic neurons. Indeed, the dopaminergic nerve terminals are densely innervated in the rat agranular insular cortex (Burkey, Carstens, & Jasmin, 1999) . In addition, D1 and D2 dopamine receptors are widely expressed in the rat and cat insular cortexes (Gaspar, Bloch, & Le Moine, 1995; Richfield, Young, & Penney, 1989) . On the basis of these findings, it is possible that nAChRs located on dopaminergic neurons are involved in the nicotine-induced inhibition of synaptic potentiation in layer 5 pyramidal neurons of the insular cortex.
Therefore, in the present study, we examined whether dopamine receptors might contribute to the nicotine-induced inhibition of synaptic potentiation. We also investigated whether dopamine receptors might contribute to the nAChR-induced enhancement of glutamatergic and GABAergic synaptic transmission. Here we demonstrate that D1 dopamine receptors are involved in the nicotine-induced inhibition of synaptic potentiation presumably through enhancing GABAergic synaptic inputs onto layer 5 pyramidal cells. The enhanced inhibitory transmission is mediated by the interaction of nAChRs with D1 dopamine receptors.
| MATERIAL S AND ME THODS
All experiments were carried out in accordance with the European Communities Council Directive of 2010/63/EU. All experimental protocols were approved by the animal ethics committees of the Osaka University Graduate School of Dentistry for the care and use of laboratory animals, and all experiments were performed in accordance with the relevant guidelines. All efforts were made to minimize the suffering as well as the number of animals.
| Slice preparation
C57BL/6J mice of both sexes at 3-5 weeks old were used in the experiments and they were purchased from Japan SLC (Hamamatsu, Japan).
They were anesthetized with isoflurane, and the brains were quickly removed from the skull and immersed in ice-cold modified artificial cerebrospinal fluid (aCSF) composed of 210 mM sucrose, 2.5 mM KCl, 2.5 mM MgSO 4 , 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 0.5 mM CaCl 2 , and 50 mM d-glucose. With a microslicer (Linearslicer Pro 7, Dosaka EM, Kyoto, Japan), coronal sections of 300 μm thickness including the insular cortex were cut. Slices were incubated at 32°C for 30 min in 50% modified aCSF and 50% normal aCSF (pH 7.3) composed of 126 mM NaCl, 3 mM KCl, 1 mM MgSO 4 , 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 2 mM CaCl 2 , and 10 mM d-glucose. The slices were then placed in normal aCSF at room temperature (20-24°C). Normal aCSF was continuously gassed with a mixture of 95% O 2 -5% CO 2 .
| Whole-cell patch-clamp recordings
Brain slices including the insular cortex were transferred to the recording chamber and perfused with normal aCSF at a flow rate of 2 ml/min.
Using a MultiClamp 700B Amplifier (Molecular Devices, Foster City, California), whole-cell recordings were made from visually identified pyramidal neurons in layer 5 of the agranular insular cortex which is associated with nicotine self-administration (Pushparaj et al., 2015) . Neurons were visualized using differential interference contrast microscopy (BX-51WI; Olympus, Tokyo). All electrophysiological experiments were performed at 30-32°C. When excitatory postsynaptic currents (EPSCs) were recorded, recording pipettes (3-5 MΩ) were filled with a solution containing 132.5 mM K-gluconate, 8.5 mM KCl, 14 mM Na-gluconate, 2 mM ATP-Mg, 0.3 mM GTP-Na 3 , 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and 0.2 mM ethylene glycol tetraacetic acid (EGTA), pH 7.3, adjusted with KOH (Sato et al., 2017) . In this internal solution, contamination by inhibitory postsynaptic currents (IPSCs) was eliminated by setting the equilibrium potential for Cl -to -70 mV. Under this recording condition, evoked postsynaptic currents were solely mediated by glutamatergic inputs onto layer V pyramidal neurons in the mouse insular cortex (Sato et al., 2017) . EPSCs were recorded at a holding potential of -70 mV. Evoked EPSCs were recorded from layer 5 pyramidal neurons, and stimuli were delivered by a monopolar tungsten-stimulating electrode placed in the deep part of layer 3 in the agranular insular cortex (Figure 1a ). EPSCs | 3 of 13 TOYODA were evoked by repetitive stimuli (duration is 100 μs, intensity is adjusted to induce EPSCs with an amplitude of 50-100 pA) at 0.033 Hz. Effects of 1 mM acetylcholine (ACh) on spontaneous EPSCs (sEPSCs) were examined in the presence of 10 μM bicuculline and 0.5 μM atropine. When IPSCs were recorded, the recording pipettes (3-5 MΩ) were filled with solution containing 130 mM Cs-gluconate, 10 mM CsCl, 2 mM MgCl 2 , 2 mM ATP-Na 2 , 0.4 mM GTP-Na 3 , 10 mM HEPES and 0.2 mM EGTA, pH 7.3, adjusted with CsOH (Toyoda et al., 2015) . The Cl -equilibrium potential (E Cl )
was calculated to be -57 mV. IPSCs were recorded at a holding potential of 0 mV. The IPSC recordings were started 10 min after establishing the whole-cell configuration and clamping at 0 mV. Effects of ACh on spontaneous IPSCs (sIPSCs) were examined in the presence of 10 μM DNQX (6,7-dinitroquinoxaline-2,3-dione, a non-NMDA receptor antagonist), 50 μM AP-5 (dl-2-amino-5-phosphonopentanoic acid, an NMDA receptor antagonist), and 0.5 μM atropine. The sealing resistance was usually more than 10 GΩ. The membrane potential values were corrected for the liquid junction potential (10 mV) between the internal solutions (negative) and the extracellular solution. Signals were low-pass filtered at 2 kHz (4-pole Bessel filter) and digitized at a sampling rate of 2-10 kHz (1440A, Molecular Devices).
| Synaptic plasticity induced by paired training
For induction of LTP, 80 presynaptic stimuli were delivered at 2 Hz while recorded neurons were held at +30 mV for the duration (40 s) of the LTP-inducing presynaptic stimulation (referred to as paired training) (Sato et al., 2017; Zhao et al., 2005) . The duration and intensity of presynaptic pulses were the same as the test stimuli. LTP was induced with paired training within 12 min after establishing the whole-cell configuration to avoid the washout of intracellular contents that are critical for the establishment of synaptic plasticity (Sato et al., 2017; Zhao et al., 2005) . Access resistance was 15-20 MΩ and was monitored throughout the experiment. Data were discarded if access resistance changed more than 15% during an experiment. To assess the effects of nicotine in these experiments, nicotine was applied before (260 s) and during 
| Drug application
To investigate how dopamine receptors modulate nicotine-induced inhibition of synaptic plasticity in layer 5 pyramidal neurons, nicotine was bath applied at concentrations of 300 nM and 10 μM. Nicotine at concentration greater than 1 μM strongly desensitizes nAChRs in the prefrontal cortex (Poorthuis et al., 2013) . Thus, studies for examining the roles of nAChRs on synaptic transmission were mainly performed by using ACh to reduce the potential impact of desensitization. In some experiments, 10 μM nicotine was used to match the experimental condition of synaptic plasticity. ACh was bath applied at 1 mM. SCH23390, a D1 dopamine receptor antagonist, and sulpiride, a D2 dopamine receptor antagonist, was bath applied at 50 μM and 10 μM, respectively (Liu, Otsu, Vasuta, Nawa, & Murphy, 2007) . SKF38393, a D1 dopamine receptor agonist, and quinpirole, a D2 dopamine receptor agonist, were bath applied at 10 μM (Onn, Fienberg, & Grace, 2003) . Atropine, an antagonist of muscarinic receptors, was bath applied at 0.5 μM. All chemicals were obtained from Sigma-Aldrich (St. Louis, Missouri).
| Statistical analysis
Synaptic plasticity was measured as the change in an EPSC amplitude when comparing an average EPSC amplitude measured in a period of 25-30 min after LTP induction to a baseline EPSC amplitude measured in the last 5 min of control recordings. The frequency and amplitude of sEPSCs and sIPSCs were analyzed using Minianalysis software (Synaptosoft, Decatur, Georgia). To evaluate the effects of ACh or nicotine on glutamatergic and GABAergic synaptic transmission, the percentage increases in frequency and amplitude of sEPSCs and sIPSCs were used and were determined by comparing the average number of events per bin (1 bin = 10 s) during the last 1 min of the control period with the average during the peak effects in which 6 bins (before, peak, and after) were averaged. SCH23390 and sulpiride had no effects on the frequencies and amplitudes of sEPSCs and sIPSCs. Numerical data were expressed as the mean ± S.E. Statistically significant differences between the groups were assessed using unpaired or paired Student's t test, Wilcoxon signed rank test, and one-way ANOVA followed by post hoc Tukey-Kramer test. The Kolmogorov-Smirnov (K-S) test of normality was first performed on each distribution. The Student's t test and one-way ANOVA were used when data showed normal distribution, whereas the Wilcoxon signed rank test was used when data did not show normal distribution. The significance of any treatment on the amplitudes of sEPSCs and sIPSCs was assessed with the K-S test for each neuron. Where described in text, Student's t tests were used to compare responses from several neurons. Statistical results were given as a precise p value, except when p was very small (p < 0.001). p < 0.05 was considered statistically significant.
| RE SULTS

| Effects of dopamine receptor antagonists on nicotine-induced inhibition of synaptic potentiation
Whole-cell patch-clamp recordings were made from visually identified layer 5 pyramidal neurons of the mouse insular cortex (Figure 1b, inset) .
The typical firing pattern of the pyramidal neurons showed firing frequency adaptation (Figure 1b ). After identification of pyramidal neurons, LTP-inducing protocol (paired training) was used to determine whether synaptic transmission undergoes LTP. Paired training produced a significant enhancement of synaptic responses (25-30 min after paired training, 131 ± 5% of baseline responses, n = 12 neurons/6 mice; paired t-test: t(11) = -5.41, p < 0.001) (Figure 1c, h ). When 10 μM nicotine was bath applied for 5 min (before and during paired training), synaptic responses were not enhanced but rather decreased (79 ± 2% of baseline responses, n = 10 neurons/5 mice; paired t test: t(9) = 7.27, p < 0.001) (Figure 1d , h). These results were consistent with our previous observations (Sato et al., 2017) . To determine whether nicotine-induced inhibition of synaptic potentiation might involve dopaminergic activities, we examined the effects of D1 and D2 dopamine receptor antagonists (SCH23390 and sulpiride, respectively) on the nicotine-induced inhibition of synaptic potentiation. When 10 μM nicotine was coapplied with 10 μM SCH23390 and 50 μM sulpiride for 5 min, the nicotine-induced inhibition of synaptic potentiation was partially inhibited (105 ± 8% of baseline responses, n = 8 neurons/4 mice; paired t-test: t (7) During smoking, the blood concentration of nicotine reaches about 300-600 nM (Matta et al., 2007) . Thus, we next investigated the effects of a lower concentration of nicotine (300 nM) with and without the D1 dopamine receptor antagonist SCH23390 on the synaptic potentiation induced by paired training. Consistent with the observations using 10 μM nicotine, bath application of 300 nM nicotine suppressed the synaptic responses (85 ± 6% of baseline responses, n = 9 neurons/5 mice; paired t-test: t(8) = 7.19, p < 0.001) (Figure 1i ). When 300 nM nicotine was coapplied with 10 μM SCH23390, nicotine-induced inhibition of synaptic potentiation was partially inhibited (107 ± 6% of baseline responses, n = 10 neurons/6 mice; paired t-test: t(9) = -1.75, p = 0.113) (Figure 1j) . A pooled data analysis among three groups (control, 300 nM nicotine, SCH23390
+ 300 nM nicotine) revealed that the magnitude of synaptic responses obtained in the presence of SCH23390 and 300 nM nicotine was significantly greater than that obtained in the presence of 300 nM nicotine alone (one-way ANOVA: F(2,28) = 30.36, p = 0.004). These results suggest that D1 dopamine receptors may be involved in nicotine-induced inhibition of synaptic potentiation. However, we cannot rule out the possibility that the D1 dopamine antagonist SCH23390 itself has some effects on the synaptic potentiation induced by paired training in layer 5 pyramidal neurons of the insular cortex. Then, we next examined the effects of SCH23390 alone on synaptic potentiation. When 10 μM SCH23390 alone was bath applied for 5 min (before and during paired training), synaptic responses were significantly enhanced (133 ± 8% of baseline responses, n = 10 neurons/6 mice; paired t-test: t(9) = -4.20, p = 0.002) (Figure 1l ). The magnitude of synaptic potentiation induced by paired training in the presence of SCH23390 was not significantly different from that obtained under the control condition (unpaired t-test: t(20) = -0.279, p = 0.783),
suggesting that SCH23390 has no effect on paired training-induced synaptic potentiation. Taken together, these results strongly suggest that D1 dopamine receptors, but not D2 dopamine receptors, contribute to nicotine-induced inhibition of synaptic potentiation.
| Effects of dopamine receptor antagonists on nAChR-induced enhancement of sEPSCs
We have previously shown that the activation of nAChRs by nicotine and ACh enhances both glutamatergic and GABAergic synaptic inputs onto layer 5 pyramidal neurons of the mouse insular cortex (Sato et al., 2017) . We next examined how dopamine receptor antagonists affect the enhancing effect of ACh on sEPSCs. Consistent with our previous observations, the frequency and amplitude of sEPSCs in layer 5 pyramidal neurons were markedly increased by bath application of 1 mM ACh (frequency: 269 ± 26% of baseline responses, paired t-test: t(10) = -6.60, p < 0.001; amplitude: 133 ± 6% of baseline responses, paired t-test: t(10) = -5.80, p < 0.001) (n = 11 neurons/6 mice) (Figure 2a-c, g ).
In the presence of 10 μM SCH23390 and 50 μM sulpiride, bath application of ACh also robustly increased the frequency and amplitude of sEPSCs (frequency: 282 ± 20% of baseline responses, paired t-test: t(10) = -9.02, p < 0.001; amplitude: 135 ± 9% of baseline responses, Wilcoxon signed rank test, p = 0.003) (n = 11 neurons/5 mice) (Figure 2d-f, g ). The enhancing effect of ACh on the frequency of sEPSCs obtained in the presence of SCH23390 and sulpiride was not significantly different from that obtained without these antagonists (unpaired t-test: t(20) = -0.40, p = 0.694) (Figure 2g ). These results suggest that dopamine receptors are not involved in the enhancing effect of ACh on sEPSCs.
| Effects of dopamine receptor antagonists on nAChR-induced enhancement of sIPSCs
We next examined how dopamine receptor antagonists affect the enhancing effects of ACh on sIPSCs. In line with our previous observation (Sato et al., 2017) , the frequency and amplitude of sIPSCs in layer 5 pyramidal neurons were markedly increased by bath application of 1 mM ACh (frequency: 307 ± 21% of baseline responses, paired t-test: t(10) = -9.80, p < 0.001; amplitude: 162 ± 13% of baseline responses, Wilcoxon TOYODA signed rank test, p = 0.003) (n = 11 neurons/5 mice) (Figure 3a-c, s) . The application of ACh in the presence of 10 μM SCH23390 and 50 μM sulpiride significantly increased the frequency and amplitude of sIPSCs (frequency: 167 ± 9% of baseline responses, paired t-test: t(8) = -7.08, p < 0.001; amplitude: 128 ± 5% of baseline responses, paired t-test: t(8) = -5.18, p < 0.001) (n = 9 neurons/5 mice), but the enhancing effects of ACh on sIPSCs obtained in the presence of SCH23390 and sulpiride were significantly smaller compared to those obtained without these 
| Effects of dopamine receptor agonists on nicotine-induced inhibition of synaptic potentiation
To confirm the involvement of D1 dopamine receptors in nicotine-induced inhibition of synaptic potentiation, the effects of dopamine receptor agonists were tested. When 10 μM nicotine was coapplied with a D1 dopamine receptor agonist SKF38393 (10 μM) for 5 min, the nicotine-induced inhibition of synaptic potentiation seemed to be facilitated (56 ± 5% of baseline responses, n = 8 neurons/4 mice; paired t-test: t(7) = 10.66, p < 0.001) (Figure 4a, c) . However, when 10 μM nicotine was coapplied with a D2 dopamine receptor agonist quinpirole (10 μM) for 5 min, the nicotine-induced inhibition of synaptic potentiation was not apparently changed (77 ± 5% of baseline responses, n = 8 neurons/4 mice; paired t-test: t(7) = 6.65, p < 0.001) (Figure 4b, c) . The magnitude of the nicotine-induced inhibition obtained in the presence of SKF38393 and nicotine was significantly larger than that obtained in the presence of nicotine alone (unpaired t-test: t(16) = 5.26, p < 0.001) while that obtained in the presence of quinpirole and nicotine was not significantly different from that obtained in the presence of nicotine alone (unpaired t-test: t(16) = 0.42, p = 0.678). These results strongly suggest that D1 dopamine receptors contribute to nicotine-induced inhibition of synaptic potentiation.
| D ISCUSS I ON
In the present study, we examined whether dopamine receptors might contribute to nicotine-induced inhibition of synaptic potentiation and to nAChR-induced enhancement of glutamatergic and GABAergic synaptic transmission. We found that D1 dopamine receptors, but not D2 
| Roles of dopamine receptors in nAChR-induced enhancement of glutamatergic and GABAergic synaptic transmission
It has been shown that the activation of nAChRs on dopamine terminals stimulates dopamine release in the rat medial prefrontal cortex and striatum (Middleton, Cass, & Dwoskin, 2004; Wonnacott, Kaiser, Mogg, Soliakov, & Jones, 2000) . In addition, it has been demonstrated that the activation of dopamine receptors inhibits glutamate release in the rat cortico-striatal terminals (Rowlands & Roberts, 1980) and that the activation of D2 dopamine receptors decreases glutamate release in the rat striatum (Yamamoto & Davy, 1992) . Thus, it was expected that the activity of dopamine receptors might modulate the nAChR-induced enhancement of glutamatergic synaptic transmission in layer 5 pyramidal cells of the mouse insular cortex. However, we found that D1 and D2 dopamine receptor antagonists had no effects on the nAChR-induced enhancement of glutamatergic synaptic transmission (Figure 2 ). Although we cannot completely exclude the possibility that dopamine receptors may affect the nAChR-induced enhancement of glutamatergic synaptic transmission, it is likely that the influence of dopamine receptors is not so robust as to cause the modulation of nAChR-induced enhancement of glutamatergic synaptic transmission.
Unlike the effects of dopamine antagonists on the nAChR-induced enhancement of glutamatergic synaptic transmission, the D1 dopamine receptor antagonist SCH23390 reduced the nAChR-induced enhancement of GABAergic synaptic transmission (Figure 3 ). It has been reported that D1 dopamine receptor agonists (SKF81297 and dihydrexidine) increase sIPSCs in the rat prefrontal cortical pyramidal neurons (Seamans, Gorelova, Durstewitz, & Yang, 2001) . Therefore, it is likely that dopamine which is released by the activation of nAChRs on dopaminergic terminals increases GABAergic synaptic transmission in layer 5 pyramidal neurons of the mouse insular cortex. The GABAergic synaptic inputs onto layer 5 pyramidal cells in the mouse agranular insular cortex are enhanced predominantly by the activation of β2-containing nAChRs expressed in non-fast-spiking cells (Sato et al., 2017) . Thus, the activation of nAChRs in dopaminergic terminals might stimulate dopamine release, which in turn activates D1 dopamine receptors in non-fast-spiking cells to stimulate GABA release.
| Possible mechanisms of nicotine-induced inhibition of synaptic potentiation in layer 5 pyramidal neurons of the mouse insular cortex
In layer 5 pyramidal neurons of the mouse insular cortex, the application of nicotine suppressed synaptic potentiation through enhancing GABAergic synaptic transmission (Sato et al., 2017) . The present study revealed that D1 dopamine receptors partially contributed to this 
synaptic event (Figure 1) . Therefore, the nicotine-induced inhibition of synaptic potentiation is likely to be caused by the interaction between nAChRs and D1 dopamine receptors. It has been reported that the interaction between nAChRs and dopamine receptors plays an important role in the induction of rat striatal long-term depression (Partridge, Apparsundaram, Gerhardt, Ronesi, & Lovinger, 2002) . The hypothetical local network assumed from the present study could be explained as depicted in Figure 5 . When LTP-inducing stimuli are applied to layer 3 in the presence of nicotine, GABAergic synaptic transmission is enhanced through the activation of nAChRs expressed in GABA interneurons located in layer 3 (direct monosynaptic inhibition) and layer 5 (polysynaptic inhibition). Concurrently with this process, dopaminergic synaptic transmission is enhanced through the activation of nAChRs expressed in dopaminergic terminals located in layer 3 (direct monosynaptic input) and layer 5 (polysynaptic input), and is followed by the enhancement of GABAergic synaptic transmission through the activation of D1 dopamine receptors expressed in GABA interneurons. Eventually, synaptic potentiation in layer 5 pyramidal neurons is suppressed by enhanced GABAergic synaptic transmission. However, we cannot exclude other possible mechanisms. Not only dopaminergic synapses but also other monoaminergic synapses, such as noradrenergic and serotonergic synapses, are known to modulate synaptic plasticity in the cortex (Meunier, Chameau, & Fossier, 2017) . Therefore, the modulation of dopamine and other monoamine release caused by the activation of nAChRs may contribute to the nicotine-induced inhibition of synaptic potentiation. In the mouse agranular insular cortex, nicotine-induced modulation of synaptic plasticity is layer-specific: nicotine suppresses synaptic potentiation in layers 3 and 5 pyramidal neurons while it facilities synaptic potentiation in layer 6 pyramidal neurons (Sato et al., 2017; Toyoda, 2018) . Thus, future studies would be necessary to demonstrate how the interaction between nAChRs and dopamine receptors modulates synaptic plasticity in layers 3 and 6 pyramidal neurons of the insular cortex.
| Functional implications
Nicotine causes addiction by acting directly on the neural circuitry which leads to reward. In particular, the dopamine system plays an important role in nicotine-induced reward processing (De Biasi & Dani, 2011) . A previous study showed that subcutaneous injections of D1 and D2 dopamine antagonists (SCH23390 and spiperone, respectively) reduced nicotine self-administration and food-maintained responding in rats (Corrigall & Coen, 1991) . In addition, subcutaneous injections of SCH23390, a D2 dopamine receptor antagonist raclopride, and a D1/D2 dopamine receptor antagonist fluphenazine suppressed nicotine-induced hyperactivity in rats (O'Neill et al., 1991) . It is well accepted that dopamine activity in the nucleus accumbens exerts crucial roles in nicotine-induced reward (Day, Roitman, Wightman, & Carelli, 2007) circuitry.
F I G U R E 5 Possible roles of nicotinic acetylcholine receptors (nAChRs) and D1 dopamine receptors (D1Rs) in synaptic plasticity in the mouse insular cortex. When LTP-inducing stimuli are applied to layer 3 in the presence of nicotine, GABAergic synaptic transmission is enhanced through the activation of nAChRs expressed in GABA interneurons located in layers 3 and 5. Concurrently with this process, dopaminergic synaptic transmission is enhanced through the activation of nAChRs expressed in dopaminergic (DA) terminals, and is followed by the enhancement of GABAergic synaptic transmission through the activation of D1 dopamine receptors expressed in GABA interneurons. Eventually, synaptic potentiation in layer 5 pyramidal neurons is suppressed by enhanced GABAergic synaptic transmission. Although we have previously shown that nearly half of layer 5 pyramidal neurons and fast-spiking interneurons express α7-containing nAChR, these receptors play minor roles in the modulation of synaptic plasticity in the insular cortex (Sato et al., 2017) . Thus, the distribution of α7-containing nAChR in pyramidal neurons and fast-spiking interneurons is not described in this schema. P, pyramidal neurons Furthermore, the D1 dopamine systems in the agranular insular cortex are considered to play important roles in nicotine-induced reward processes (Kutlu et al., 2013) . Therefore, our findings may underlie the cellular and synaptic mechanisms of nicotine addiction associated with the insular cortex. However, it may be difficult to conclude from the present study whether these mechanisms are responsible for nicotine addiction because our data were obtained from naïve animals which were not addicted to nicotine. In future studies, more extensive studies of the roles of nAChRs and dopamine receptors on synaptic potentiation and their behavioral relevance would be necessary for understanding the neural mechanisms of nicotine addiction.
The interaction of nAChRs and dopamine receptors plays essential roles in not only nicotine addiction but also cognitive behaviors such as working memory. The radial maze performance, which is associated with spatial working memory in rats, was enhanced by nicotine (Levin & Rose, 1991; Levin, Rose, & Abood, 1995) , but was impaired by a nAChR antagonist mecamylamine (Levin, Castonguay, & Ellison, 1987) . The mecamylamine-induced impairment of the radial maze performance was reversed by a D2 dopamine receptor agonist LY-171555 but not a D1 agonist SKF38393 (Levin, McGurk, Rose, & Butcher, 1989) . In addition, co-administration of mecamylamine and a D2 dopamine receptor antagonist raclopride caused a significant impairment of radial maze performance compared to the effect of mecamylamine or reclopride alone, whereas interactive effects were not observed between mecamylamine and SKF38393 (McGurk, . The interaction of nAChRs and D1 dopamine receptors is likely to be related with reference memory function. In chronically nicotine-treated rats, reference memory errors were significantly increased by a D1 dopamine receptor agonist dihydrexidine while they were significantly decreased by a D1
antagonist SCH23390 (Levin, Kim, & Meray, 1996) . In layer I interneurons of the mouse prefrontal cortex, stimulation of D1/D5 dopamine receptors has been demonstrated to suppress α7 nAChRs through the activation of protein kinase A (Komal, Estakhr, Kamran, Renda, & Nashmi, 2015) . This finding also indicates that the interaction of nAChRs and dopamine receptors may modulate neural excitability in the prefrontal cortex, and ultimately affect cognitive behaviors. Furthermore, several human studies have shown evidence for the interacting effects of genetic variation in nAChRs and D2 dopamine receptors. The interaction between nAChR α4 gene (CHRNA4) and D2 dopamine receptor (DRD2) was demonstrated to be involved in working memory (Markett, Montag, & Reuter, 2010) and striatal gray matter volume (Markett, Reuter, Montag, & Weber, 2013) . Also, the interaction between nAChR α5 gene (CHRNA5) and DRD2 was shown to be associated with working memory and prefrontal gray matter volume (Di Giorgio et al., 2014) . Thus, the importance of the interaction between nAChRs and dopamine receptors has been elicited at the gene level. Considering that the insular cortex is involved in various sensory and cognitive functions such as pain perception, self-awareness, and attention (Nieuwenhuys, 2012) , the interaction between nAChRs and dopamine receptors may play critical roles in these functions.
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